FMP
NASDAQ
1.82 USD
0.09 (4.95%)
Mr. Alon Ben-Noon
Healthcare
Biotechnology
https://www.neurosense-tx.com
NASDAQ
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
0001875091
IL0011809592
M74240108
Building B
972 9 799 6183
IL
14
Dec 9, 2021
0001875091
NASDAQ
Biotechnology
Healthcare
M74240108
IL0011809592
IL
1.82
1.59
298.27k
24.87M
-
0.4-2.33
0.29
-
-
-
-
-1.94
-
https://www.neurosense-tx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.